adverse drug reactions
-
Cutting-edge genomic technology to help improve medication safety for children in new BC Children’s led study
For the past 20 years, the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) has been working to identify why patients have different responses to drug treatments. As part of a recent $200 million Genome Canada initiative, Dr. Bruce Carleton will be leading a new $17 million project to expand on the work of the CPNDS to make medications safer for…
-
Why medicine for kids is more than a smaller adult dose
More than half of all children receive at least one prescription medication a year. Despite this, few drugs have pediatric formulations. In North America and Europe, more than 75 per cent of pediatric prescriptions are considered off-label, meaning children are being prescribed medications that were never studied in their age group. Off-label use is associated…
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.
for media